Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;71(Suppl 2):1060-1068.
doi: 10.1007/s12070-017-1120-7. Epub 2017 Apr 25.

Cinnarizine: A Contemporary Review

Milind Vasant Kirtane  1 , Anita Bhandari  2 , Prashant Narang  3 , Ravi Santani  3
Affiliations

Cinnarizine: A Contemporary Review

Milind Vasant Kirtane et al. Indian J Otolaryngol Head Neck Surg. 2019 Nov.

Abstract

Cinnarizine, is approved for nausea, vomiting, motion sickness, inner ear disorders and is considered as first-line pharmacotherapy for management of vertigo. It acts by anti-vasoconstrictor activity, reducing blood viscosity and reducing nystagmus in labyrinth. Lack of adequate literature on clinical evidence of cinnarizine and its combination (dimenhydrinate) in vertigo management prompted this review. A specific MEDLINE literature search strategy was designed combining Medical Subject Headings, free-text keywords (like cinnarizine and vertigo) using Boolean operators (1970-2016) for clinical studies, clinical reviews and meta-analyses of cinnarizine. Analyses of studies validated cinnarizine's efficacy in peripheral and central vertigo versus placebo or other therapies, and was well-tolerated by the patients recruited across different studies. Cinnarizine and/ or its combinations are favorable in management of vestibular disorders wherein cinnarizine acts predominantly peripherally on labyrinth and dimenhydrinate acts centrally on vestibular nuclei and associated centers in brainstem. Combination therapy of cinnarizine and/ or its combinations demonstrated a better safety profile than either of the mono-components, offering a viable therapeutic option in vertigo management.

Keywords: Cinnarizine; Dimenhydrinate; Drug combinations; Vertigo.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestNone.

Figures

Fig. 1
Fig. 1
Mechanism of action of cinnarizine. RBC red blood cell
Fig. 2
Fig. 2
Mechanism of action of fixed dose combination of cinnarizine and dimenhydrinate
See this image and copyright information in PMC

References

    1. Emanuel MB, Will JA. Cinnarizine in the treatment of peripheral vascular disease: mechanisms related to its clinical action. Proc R Soc Med. 1977;70:7–12. - PMC - PubMed
    1. Soto E, Vega R. Neuropharmacology of vestibular system disorders. Curr Neuropharmacol. 2010;8:26–40. doi: 10.2174/157015910790909511. - DOI - PMC - PubMed
    1. National formulary of India, fourth edition, 2011. http://www.cdsco.nic.in/writereaddata/NFI_2011%20(1).pdf. Accessed 17 Oct 2016
    1. Drugs Controller General of India. List of approved drug from 01.01.2010 to 31.12.2010. http://www.cdsco.nic.in/writereaddata/list-of-approved-drug-from-01-01-2.... Accessed 17 Oct 2016
    1. Oosterveld WJ. Cinnarizine in the vertiginous syndrome. In: Towse G, editor. cinnarizine and the vertiginous syndrome. International Congress and Symposium Series No. 33. London: Royal Society of Medicine and Academic Press Inc; 1999. pp. 29–37.

LinkOut - more resources